pancreatitis and glp-1 PSCs GLP-1R: occurrence in normal pancreas, acute/chronic and effect of their activation by a GLP-1R agonist Glucagon-Like Peptide-1 Receptor Agonists Use...
Description
Exploring gastrointestinal and hepatobiliary adverse events in GLP-1 receptor agonists therapy: a large cohort retrospective study
This is another limitation of Januvias uses
Among individuals with obesity, MASLD prevalence exceeds 75%, whereas type 2 diabetes is associated with MASLD in 55%-70% of cases
People with less body fat are more at risk
